RECRUITINGINTERVENTIONAL
RSV Burden in Outpatient and Hospital Settings
Ambulatory Respiratory Tract Infection Survey, Burden of Respiratory Syncitial Virus in the Era of Covid-19
About This Trial
Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)
Who May Be Eligible (Plain English)
Who May Qualify:
- children under 24 months of age (≤)
- One of the holders of parental authority signed the consent
- Patient affiliated to a social security scheme (Social Security or Universal Medical Coverage)
- Acute purulent otitis media (Paradise Criteria) or otorrhea with or withitout associated bronchiolitis
Who Should NOT Join This Trial:
- Age \>24 months
- Refusal by one of the parents
- Not affiliated to a social security system
- Maternal RSV vaccination during the pregnancy of the included child
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* children under 24 months of age (≤)
* One of the holders of parental authority signed the consent
* Patient affiliated to a social security scheme (Social Security or Universal Medical Coverage)
* Acute purulent otitis media (Paradise Criteria) or otorrhea with or withitout associated bronchiolitis
Exclusion Criteria:
* Age \>24 months
* Refusal by one of the parents
* Not affiliated to a social security system
* Maternal RSV vaccination during the pregnancy of the included child
Treatments Being Tested
DIAGNOSTIC_TEST
nasopharyngeal samples
rapid antigen test for Sars Cov-2, influenza and RSV.
Locations (1)
ACTIV
Créteil, France